Live · updated just now · 26 stories in 24h

← Stream
ETFs & Funds Unverified First seen

Sofinnova Partners closes Crossover II fund at €725 million, above target

Sofinnova Partners announced on November 16 the final close of its Sofinnova Crossover II fund at €725 million ($815 million), above its target, according to HedgeCo.Net. The Paris-, London- and Milan-based life sciences venture firm said the fund will back late-stage European life sciences companies.

Why “Unverified”

  • Reported by HedgeCo.Net alone, with no second source or primary confirmation yet

1 independent source group across 1 post · evidence score 40/100. How labels work

What the sources claim

  1. Sofinnova Partners announced the final close of Sofinnova Crossover II at €725 million.

    “announced on November 16 the final close of Sofinnova Crossover II at €725 million”
    HedgeCo.Net
  2. The fund closed above its target.

    “Closed Its Crossover II Fund at €725 Million, Above Target”
    HedgeCo.Net
  3. The fund is aimed at backing late-stage European life sciences companies.

    “to Back Late-Stage European Life Sciences Companies”
    HedgeCo.Net

Sources

More in ETFs & Funds

All ETFs & Funds stories →

Embed this page

Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-16 12:00 UTC. Labels are computed from the sources, not by the model.